Articles tagged with Bacterial Infections
Researchers at USC developed a new peptide that stimulates the host's immune response to fight bacterial infections, offering an alternative to antibiotics. The peptide, MTD12813, is highly effective in clearing infections and modulates inflammation, reducing the risk of complications.
A new study by researchers at the University of Copenhagen found that an imbalance in vaginal bacteria is associated with a higher risk of emergency caesarean section. The study analyzed 1,396 samples from 736 pregnant women and discovered that those with greater levels of imbalance were more likely to deliver via C-section.
The University of Cincinnati College of Medicine has developed an ointment called AB569 that kills virtually all pathogenic bacteria, including multidrug resistant Pseudomonas aeruginosa. This study shows the topical drug enhances wound healing in various burn injuries.
Researchers have developed a comprehensive Lyme disease dashboard to define hotspots and map the disease across the US and Canada. The dashboard provides valuable insights for public health awareness and research collaboration.
Researchers from Trinity College Dublin investigate the epidemiology and population biology of Enteroccocus faecium, a high-priority pathogen. They found that Irish isolates have evolved independently and are diverse, with a unique genetic transposon element encoding vancomycin resistance.
A recent study found that antibiotic resistance rates for Helicobacter pylori are decreasing in European countries. The use of three antibiotics over 10-14 days resulted in success rates of over 90%. The researchers hope to reduce antibiotic consumption to prevent further resistance.
Researchers at Karolinska Institutet found that certain bacteria from the digestive system can cause damage to pancreatic cells, increasing the risk of malignant tumours. The study suggests that antibiotics could prevent this damage, offering a potential prophylactic intervention.
Scientists have clarified phytochrome's atomic-scale resolution, unlocking its role in regulating bacterial pathogenicities. The study provides a new photoactivation model explaining the signaling mechanism of black rot disease.
Researchers have found that ultrashort-pulse lasers can inactivate antibiotic-resistant bacteria and bacterial spores, reducing their numbers by over 1,000 times. The technology has the potential to be used to sterilize wounds and disinfect blood products, and may also be used to treat bloodstream infections.
Researchers at Harvard's Wyss Institute have developed a microfluidic Organ Chip device that accurately models cystic fibrosis lung airway pathology. The model replicates key pathological hallmarks, including mucus layer changes and inflammatory responses, providing a comprehensive preclinical human model for investigating new therapies.
Researchers at the University of Texas at Dallas have developed a vaccine method against recurrent urinary tract infections (UTIs) using metal-organic frameworks. The new approach produces substantially enhanced antibody production and significantly higher survival rates in mice compared to standard vaccine preparation methods.
Researchers from SMART and TLL have developed a rapid Raman spectroscopy-based method to detect and quantify early bacterial infection in crops. This method enables non-invasive early diagnosis, which is crucial for plant disease management and agricultural productivity.
Research using ring-tailed lemurs shows that fecal microbiota transplants can stabilize and restore a healthy gut microbiome after antibiotic use. The study confirms the effectiveness of this ancient treatment for reducing the negative effects of antibiotics on the gut, which can cause severe diarrhea and abdominal pain.
A study by Anglia Ruskin University has identified potentially dangerous Pseudomonas bacteria in 21% of wild bird faeces collected from locations near the River Cam. The bacteria, which can be passed on to humans through cross-contamination, were resistant to multiple antibiotics.
Researchers have identified compounds that interfere with fungal enzymes required for fatty acid synthesis, potentially overcoming resistance to current treatments. These compounds show promise as antifungal agents, effective even against drug-resistant strains of fungi.
Researchers at Hebrew University of Jerusalem discover a 'disrupted' state in bacteria that resists current antibiotics, requiring new pharmacological agents to combat. The breakthrough model predicts bacterial population responses to treatments, offering avenues for better treatments against cancer cells.
A rapid same-day test has been developed to identify secondary infections in COVID-19 patients on intensive care, allowing for targeted antibiotic treatment and reduced risk of antimicrobial resistance. The test uses nanopore sequencing technology to analyze bacterial and fungal pathogens present in patient samples.
Scientists at the University of Southampton have created nanoparticles that can target and kill deadly bacteria hiding in human cells. The breakthrough could lead to a new treatment method using injectable or inhalation-based antibiotic-laden capsules, potentially saving thousands of lives annually.
Zheng's sensor can determine effective antibiotics for treating bacterial infections in patients, providing detailed information about microbial growth faster and more sensitively than conventional approaches. The device achieves single-cell spatial resolution and 15-second temporal resolution over a centimeter-scale field of view.
Research identifies way of using nanoparticles to target and disrupt bacterial cells, making them more susceptible to standard antibiotic treatments. Laboratory studies show a strong effect in killing a range of bacteria, including some linked to hospital-acquired infections.
A new technique measures bacterial metabolic activity with an electric probe to identify antibiotic resistance in less than 90 minutes. This rapid method enables doctors to quickly determine which antibiotics will or won't work for a patient's infection, improving treatment decisions and potentially saving lives.
A global review found bioaerosols can be transmitted throughout a building by defective plumbing and that opening toilet lids after flushing disperses contaminated droplets. Uncovered rubbish bins and poor surface cleaning also contribute to high bacterial loads.
The study found that all 86 tridomain homologues of NDP-heptose synthetases are conserved in Actinobacteria, with three types of gene clusters encoding different natural products. The kinase domains of four selected proteins were found to be dysfunctional.
Researchers at Karolinska Institutet discovered that interleukin-26 plays a critical role in bacterial pneumonia by directly killing bacteria and modulating the immune system. This finding positions IL-26 as a new potential target for biological treatment of pneumonia, an increasing global health threat.
A new study reveals that mice infected with bacteria or parasites develop a unique tolerance mechanism to shield their enteric neurons from death. This finding has potential clinical implications for conditions like irritable bowel syndrome, where neuronal loss can lead to severe gastrointestinal disease.
A study published in The Lancet Infectious Diseases found that temocillin was effective in treating febrile urinary tract infections with fewer resistant bacteria. Temocillin acts specifically against E. coli and other intestinal bacteria, reducing the risk of treatment failure.
Chromobacterium violaceum uses zinc ion transporter ZnuABC to overcome host constraints on metal availability, increasing its virulence. The discovery offers a route for novel therapies against bacterial infections.
A new research discovery at Monash University has found a way to make antibiotics more effective against 'superbugs' by attaching chemoattractants to antibiotics, enabling the recruitment of immune cells and improving killing ability. The findings have shown a 2-fold increase in effectiveness with lower doses.
Researchers have recorded the sharpest images of living bacteria, revealing a complex architecture that makes them harder to kill by antibiotics. The study found that bacteria with protective outer layers may have stronger and weaker spots on their surface.
Researchers found a higher burden of infection, more inflammation, and lower diversity of microorganisms in children with cystic fibrosis compared to disease controls. This divergence was noted as early as toddlerhood, suggesting potential for earlier treatment and prevention of severe lung disease.
Researchers at the University of Bonn discovered a novel resistance mechanism in Staphylococcus aureus, which protects the bacteria from vancomycin. By binding vancomycin to its cell wall, the strain prevents the antibiotic from reaching the membrane and killing the bacteria.
Researchers found that Pseudomonas aeruginosa populations in CF patients' sinuses vary widely, with evolution following two stages: pathoadaptive community formation and fragmentation. This discovery may inform new therapeutic approaches by focusing on strongest evolutionary pressures.
Researchers identified a bacterium on healthy cats that produces antibiotics against severe skin infections in humans and pets. The discovery may lead to new treatments for MRSP infections in dogs and potentially other inflammatory skin diseases.
A potential new therapy for urinary tract infections has been discovered using the FDA-approved anti-inflammatory drug dimethyl fumarate, which activates the NRF2 pathway. This balance between eliminating bacteria and minimizing tissue damage is crucial to treating UTIs.
A new study suggests that a novel treatment involving the administration of an enzyme that degrades neutrophil nets may prevent brain swelling and improve waste clearance in rats with bacterial meningitis. The treatment could be combined with antibiotics if needed.
Researchers found that vitamin D supplementation with calcidiol increased the expression of genes related to cell adhesion and migration, pathogen recognition, and pathogen killing in dairy cows. This suggests a possible link between vitamin D and enhanced immune function, particularly during early lactation.
A new hydrogel treatment kills drug-resistant bacteria, including MRSA, and induces the expression of naturally-existing antimicrobial peptides in human skin cells. The gel is non-toxic, biodegradable, and scalable.
Researchers identify beneficial bacteria like Klebsiella oxytoca that can combat hospital germs like K. pneumoniae. The study found that co-infection with these 'good' bacteria reduces susceptibility to infections and promotes a quicker recovery after antibiotic therapy.
BIDMC researchers found a link between high toxin levels and disease severity in patients with suspected C. difficile infections. The study developed a highly sensitive test to measure toxin concentrations, paving the way for more predictive tests.
Researchers found that nanosilver treatment can increase the risk of recurrent infections when used long-term due to pathogen adaptation. Long-term exposure allows bacteria like Pseudomonas aeruginosa to evolve and resume normal growth upon discontinuation of treatment.
Researchers from the University of Seville discovered that a single amino acid mutation in Salmonella enzymes enables them to modify more proteins in infected cells, leading to increased virulence. This finding has significant implications for developing inhibitors as alternative antibacterial treatments.
A national review of nocardia infection in kidney transplant patients found that those with compromised immune responses are more vulnerable to the opportunistic agent. Nocardiosis can lead to pneumonia and brain abscess, and screening is crucial, especially in combination with pneumonia symptoms.
A new study by Oxford academics found that approximately 20% of flies and cockroaches carry carbapenem resistance, while 70-80% carry extended spectrum cephalosporin resistance. Climate change could lead to a doubling of insect populations and an increase in the global spread of antibiotic resistance.
Researchers have identified a new prophage-mediated defence system in Salmonella Typhimurium ST313 called BstA, which efficiently suppresses phage attacks. This discovery opens up a new avenue of research and could potentially lead to the development of new biotechnologies.
Researchers at IOCB Prague have developed a novel antibacterial material called NANO-LPPO that can prevent infection and facilitate treatment of skin wounds. The material combines lipophosphonoxins with a nonwoven nanotextile, which releases active substances in response to bacterial presence.
Studies found distinct patterns in nasal microbiota of individuals infected with SARS-CoV-2, with symptomatic patients showing reduced bacterial counts and increased presence of certain bacteria. The findings suggest that altered microbiota may impact immune response to the virus.
A special issue of PLOS Medicine explores the social determinants of child and adolescent health, including poverty, pollution, and violence. The studies focus on the intersection of child health and challenging environments, highlighting urgent redirective strategies to achieve the UN Sustainable Development Goals.
Researchers investigate Pseudomonas cannabina pv. alisalensis (Pcal) interaction with cabbage and oats, discovering coronatine (COR) suppresses salicylic acid to aid pathogen growth. This finding opens doors to new disease control strategies.
Researchers at Duke University developed an antibiotic coating that can be applied to orthopedic implants before surgery, eliminating the risk of infection. The coating, made from two polymers and an antibiotic, prevents bacterial colonization and can be personalized for individual patients.
Scientists have developed a new therapy that combines bacteriophages with antibiotics to treat antibiotic-resistant infections, specifically targeting Mycobacterium abscessus. The treatment, using the bacteriophage 'Muddy', showed significant improvement in survival rates and severity of infections when paired with rifabutin, demonstra...
A new study from Cornell University has found that the antimicrobial properties of certain stem cell proteins can effectively reduce the viability of methicillin-resistant Staphylococcus aureus (MRSA) in skin wounds. The treatment also stimulates the surrounding skin cells to build up a defense against the bacterial invader.
Researchers have created a flexible polymer composite microneedle array that can effectively pierce biofilm in chronic wounds, delivering oxygen and bactericidal agents simultaneously. This innovation has the potential to improve treatment outcomes for millions suffering from diabetic foot ulcers.
A study found that treating wounds with mesenchymal stromal cell secretions significantly reduced MRSA viability and stimulated the surrounding skin cells to build a defense. The treatment has potential as an alternative to antibiotics, reducing antibiotic resistance in both veterinary and human medicine.
Researchers at Tel Aviv University have created a system that enables the production of 'good' bacteria capable of eliminating 'bad' bacteria. This breakthrough technology uses a toxin injection system to target specific types and amounts of toxins, offering an alternative to antibiotics.
Researchers suggest that protecting the microbiome is crucial in preventing and fighting off infections with harmful, drug-resistant bacteria. By preserving a healthy balance of beneficial microorganisms, individuals can reduce their susceptibility to these types of infections.
Researchers at Vanderbilt University Medical Center have identified a new antibacterial mechanism where immune cells cooperate to capture and 'eat' bacteria. This cooperation enhances the killing power of macrophages, increasing phagocytosis of bacterial pathogens, including antibiotic-resistant staph
A mechanical engineering faculty-researcher at RIT is developing a microfluidic device to improve the detection of drug-resistant bacteria in blood, which can cause severe infection and death. The goal is to detect these strains early, allowing for prompt treatment and recovery.
Researchers discovered a DNA modification system that coordinates bacterial replication in TB. The DarT/DarG system can be targeted by new antibiotics, offering hope for treating the deadly disease.
Researchers discovered that natural killer cells play a crucial role in wound healing by accelerating blood vessel growth. However, this process increases the risk of bacterial infections. The study suggests harnessing killer cells to fight antibiotic-resistant bacteria and finding a balance between wound healing and immune defense.
A team of researchers characterized different bacterial populations isolated from the International Space Station's potable water system, exploring their functional properties and long-term interactions. The study aimed to improve microbial risk assessments for human-built environments in space and on Earth.